Subscribe to our Newsletters !!

    rapid test

    Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™

    Mechelen, Belgium, 6 October 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release of SeptiCyte® RAPID on Idylla™ as a CE-marked IVD test. SeptiCyte® RAPID is a host-response test1 that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and

    Optimized Tube Plate for Enzyme Studies

    BioChromato Inc. has developed an enzyme assay product – the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies. The TP-600 is manufactured from ultra-pure polypropylene that does not contain any enzyme inhibitors such as EDTA or other contaminants that may degrade your assay results. In addition,